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ABSTRAK
Disfungsi seksual di kalangan pesakit kanser ginekologi adalah prevalens. Pada 
kebanyakan situasi, disfungsi seksual di kalangan penderita kanser ginekologi adalah 
di bawah paras pengenalpastian di mana terdapat pelbagai faktor morbiditi psikologi, 
faktor berpelbagaian yang berinteraktif berserta kengganan pesakit menceritakan 
masalah mereka kepada doktor perawat. Menentukan faktor berisiko disfungsi 
seksual di kalangan pesakit akan membuka ruang untuk kita memberi lebih perhatian 
kepada golongan yang memerlukan perhatian serta membolehkan satu strategi 
untuk mengenalpasti disfungsi seksual di peringkat awal, agar usaha pencegahan 
dan rawatan boleh dilaksanakan. Kajian ini bertujuan untuk menentukan prevalens 
dan faktor berisiko disfungsi seksual di kalangan pesakit kanser ginekologi di 
Hospital Sultanah Bahiyah, Alor Star. Fungsi seksual dikalangan 83 penderita kanser 
ginekologi yang berkahwin dinilai dengan skala swa-penilaian MVFSFI (Malay version 
Female Sexual Function Index). Skala swa-penilaian WHOQOL-BREF (World Health 
Organization-Quality of Life-26) yang digunakan untuk menilai domain kualiti 
kehidupan sementara MINI (Mini International Neuropsychiatry Interview) pula 
untuk menilai masalah psikiatri di kalangan pesakit. Kadar prevalens disfungsi seksual 
di kalangan pesakit kanser ginekologi ialah 65% (54/83).  Disfungsi seksual berkait 
secara signifikan dengan tahap pendidikan yang rendah (kadar odds, OR: 3.055; sela 
keyakinan, CI 1.009-9.250), tempoh penderitaan kanser yang pendek (OR 0.966, 
CI 0.966- 0.998), rawatan kemoterapi yang berterusan  (OR 3.045, CI 1.149-8.067), 
persepsi tentang kesakitan (OR 3.230, CI 1.257-8.303), kurangnya perhubungan seks 
(OR 1.862) dan tiga domain kualiti kehidupan termasuk kesihatan fizikal, psikologi 
dan perhubungan sosial (masing-masing OR 0.942, CI 0.908-0.978; OR 0.955, CI 
0.916-0.995; OR 0.933, CI 0.894-0.973). Walaubagaimana pun, disfungsi seksual 
tidak berkait dengan kemurungan yang dialami oleh penderita kanser ginekologi 
(χ2 = 1.224, p = 0.268). Kesimpulannya, prevalens disfungsi seksual di kalangan 
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penghidap kanser ginekologi adalah tinggi, sama seperti kajian-kajian lain yang 
telah dijalankan. Memandangkan prevalens disfungsi seksual adalah berpelbagaian 
dimensi, justeru proses penilaian dan perawatan seharusnya mendukung konsep 
holistik serta berorientasikan pesakit.
Kata kunci: kanser ginekologi, disfungsi seksual, faktor risiko, kualiti kehidupan
ABSTRACT
Sexual dysfunction is highly prevalent in gynaecological cancer patients. Most of 
the time, sexual dysfunction in gynaecological cancer is underdiagnosed as there 
is overlapping of symptoms with other psychological morbidities, interplaying of 
multiple risks, patients’ reluctance to complain or incompetence of health care 
provider to assess. Determining the risk factors of sexual dysfunction in cancer 
patients enables us to pay more attention to those who are vulnerable and to device 
strategies for early detection, prevention and treatment of sexual dysfunction in them. 
The main aim of the study was to determine the prevalence of sexual dysfunction and 
its risk factors in gynaecological cancer patients in Hospital Sultanah Bahiyah, Alor 
Star, Malaysia. Sexual function of eighty-three gynaecological cancer patients who 
were married were assessed with self-rated MVFSFI (Malay version Female Sexual 
Function Index). Self-rated WHOQOL-BREF (World Health Organization- Quality 
of Life- 26) which assessed the domains of quality of life was used while MINI (Mini 
International Neuropsychiatry Interview) was used for diagnosis of major depressive 
disorder. The prevalence of sexual dysfunction among the married gynaecological 
cancer patients was 65% (54/83).  Sexual dysfunction was significantly associated 
with low education level (OR 3.055, CI 1.009-9.250), shorter duration of cancer 
(OR 0.966, CI 0.966- 0.998), ongoing chemotherapy (OR 3.045, CI 1.149-8.067), 
pain perception (OR 3.230, CI 1.257-8.303), absence of sexual intercourse for more 
than one month (OR 1.862) and three domains of quality of  life such as physical 
health, psychological health and social relationship (OR 0.942, CI 0.908-0.978; OR 
0.955, CI 0.916-0.995; OR 0.933, CI 0.894-0.973, respectively). However, sexual 
dysfunction was not associated with major depressive disorder (χ2² = 1.224, p = 
0.268). The prevalence of sexual dysfunction in gynaecological cancer patients was 
comparable to other studies of similar population. Since, the risk factors of sexual 
dysfunction in gynaecological cancer patients are multidimensional, the process of 
assessment and management need to be holistic and patient-oriented.  
Keywords: gynaecological cancer, sexual dysfunction, risk factors, quality of life
a significant cause of morbidity and 
mortality worldwide. In the United 
States of America, ovarian cancer 
is one of the most deadliest and 
INTRODUCTION
Throughout the world, cancer 
involving the female genital tract is 
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common gynecological cancer in 
female. In Malaysia, the most common 
gynaecological cancer is cervical 
cancer, followed by ovarian cancer. 
According to The National Cancer 
Registry 2003 for Peninsular Malaysia 
showed that over 1,500 women 
developed cervical cancer of which 
700 died each year. Yet, cervical 
cancer is the most preventable cancer 
in the general population. According to 
the National Cancer Registry, ovarian 
cancer happens to be the fourth most 
common cancer amongst females in 
Peninsular Malaysia and accounts for 
5% of all cancer cases seen in female 
(Lim & Halimah 2004).
 There is high prevalence of 
gynaecological cancer in Malaysia. 
However, proper research on the sexual 
dysfunction affected by the cancer 
is still lacking. In community-based 
studies, female sexual dysfunction is 
found to be highly prevalent in many 
countries and it ranges between 25% 
- 63% (Laumann et al. 1999; Brock et 
al. 2003). A prevalence of 30% has 
been reported in many Asian countries 
such as Hong Kong, Japan, Korea, 
Taiwan and Singapore (Nicolosi et 
al. 2005). Female sexual dysfunction 
can be categorized into sexual desire 
disorder, sexual arousal disorder, sexual 
lubrication problem, sexual orgasmic 
disorder, sexual satisfaction problem 
and sexual pain disorder (American 
Psychiatric Association 1994).
 There are reports of sexual complaints 
in up to 90% of females diagnosed 
with cancer (Anderson 1990). With the 
cancer affecting the female genitalia 
organs directly, it is believed that its 
prevalence among gynaecological 
cancer patients is even higher, ranging 
from 40 to 100% (Casey 1996). The 
cancer effects such as vaginal dryness, 
pain or discomfort during penetration 
and smelly vaginal discharge can 
cause emotional distress (Taylor 2000). 
Dysfunction may also result from the 
treatment that is aimed at curing or 
containing disease such as radiotherapy 
and chemotherapy, or as a result of the 
psychological distress experienced by 
the patient and/or her partner during 
diagnosis and treatment (Amsterdam & 
Krychman 2008; Schover 1997; Schover 
& Jensen 1998; Anderson 1999). 
Other than gynaecological cancers, 
pain, medication, antidepressants, 
medical conditions such as diabetes, 
stroke, neurological problem and 
pain of osteoarthritis can cause sexual 
dysfunction direct or indirectly. 
To highlight, the causes of sexual 
dysfunction in gynaecological cancer 
patients are multidimensional and all of 
the possibilities for multiple causations 
or risk factors need to be reviewed. 
 Majority of gynaecological cancer 
patients with sexual dysfunction 
were untreated due to many reasons 
(Schover 1997). In the busy clinic and 
ward setting, health care providers 
and patients may not have the luxury 
of time and privacy to discuss about 
their concerns (Marwick 1999). Doctors 
and patients may also have their own 
personal discomfort to discuss sexual 
matters. This can be more obvious 
when the physician is a male doctor. 
Patients’ husbands are also excluded 
most of the time during assessment of 
sexual function. The doctors’ interviews 
and assessments may be limited by 
their lack of expertise and knowledge. 
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MATERIALS AND METHODS
Following approval by the Department 
of Psychiatry, ethics committee of 
Hospital Universiti Kebangsaan 
Malaysia (HUKM) and National Medical 
Research register (NMRR) necessary 
permission was obtained from the Head 
of Department of Gynae-oncology 
Hospital Sultanah Bahiyah, Alor Star, 
Malaysia. The samples were eventually 
gathered over a period of five months. 
The sample comprised patients 
diagnosed with gynaecological cancer 
who were receiving treatment. Eligibility 
criteria included age 18 years or older, 
ability to communicate effectively and to 
give informed consent. Exclusion criteria 
included patients with history of drug 
abuse, significant cognitive impairment, 
patients who refused to give consent 
and unable to communicate. Subjects 
were interviewed using questionnaires 
that included socio-demographic 
variable (i.e. age, ethnicity, religion, 
marital status, occupation, education 
level, husband’s help in the household, 
presence of husband and children less 
than 18 years old at home and perceived 
social support) and medical variable 
(i.e. type of cancer, staging, cancer 
treatment modalities, pain perception, 
perceived social support, medical illness 
and psychiatric illness). Furthermore, 
three more questionnaires such as Mini 
International Neuropsychiatry Interview 
(MINI), Malay Version Sexual Female 
Sexual Function Index (MVFSFI) and 
World Health Organization Quality 
of Life (WHOQOL-BREF) were used. 
MINI was developed by Sheehan et al. 
(1998), MVFSFI and Malay version of 
WHOQOL-BREF have been validated 
and used previously in other studies 
(Sidi et al. 2007; Hasanah et al. 2003). 
In MVFSFI, the cut off total score for 
sexual dysfunction was ≤55 and the 
cut off score for each domain of sexual 
dysfunction: ≤five for the sexual desire 
disorder (sensitivity 95% and specificity 
89%); nine for sexual arousal disorder 
(sensitivity 77% and specificity 95%); 
10 for disorder of lubrication (sensitivity 
79% and specificity 87%); four for 
orgasmic disorder (sensitivity 83% 
and specificity 85%); 11 for sexual 
dissatisfaction (sensitivity 83% and 
specificity 85%); and ≤ seven for sexual 
pain disorder (sensitivity 86% and 
specificity 95%). All data were analysed 
using the Statistical Package for Social 
Sciences (SPSS) version 11.5 computer 
program. 
 Initially the individual effects of 
the socio-demographic and medical 
variables were tested. Student t-Test was 
used to analyze normally distributed 
quantitative variables such as age group. 
To analyze not normally distributed 
quantitative variables such as cancer 
duration, duration of absence of sexual 
intercourse among married patients, 
scoring of the MVFSFI and WHOQOL-
BREF, Mann-Whitney U test was 
performed. Binary logistic regression 
test was used to analyze association 
between sexual dysfunction and those 
variables that deemed significant in the 
univariate and bivariate tests. Socio-
demographic and medical variables that 
deemed significant (such as education 
level, duration of cancer, ongoing 
chemotherapy, pain perception and 
quality of life aspects such as physical 
health, psychological health and social 
relationship) were concurrently entered 
into the logistic regression. 
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RESULTS
Eighty-three out of 120 (69%) patients 
were married. The rest (37, 31%) 
were single, widowed, separated or 
divorced. All patients from the latter 
group denied having sexual partners 
and were excluded in the assessment 
of sexual dysfunction. With the cut-off 
point 55 or less for sexual dysfunction, 
the prevalence of sexual dysfunction 
was 65% (54/83). 
 The number of patients with 
desire dysfunction was 64 (77%), 
sexual arousal dysfunction (54, 65%), 
sexual lubrication problem (59, 71%), 
orgasmic dysfunction (47, 57%), sexual 
satisfaction problem (58, 70%) and 
sexual pain problem (47, 57%). 
 With regards to the cancer subjects 
who were married, 44 out of 83 (53%) 
married patients did not have sexual 
intercourse with their spouses for 
more than one month. The duration of 
absence of sexual intercourse ranged 
from 2 months to 240 months (median 
= 12 months) (IQR = 5 to 24 months).
 Table 1 and 2 represents the 
relationship of sexual dysfunction 
with psychosocial variables, medical 
variables and domains of quality of life. 
 It depicts that sexual dysfunction 
was significantly associated with 
education level (OR 3.055, 95% CI 
1.009-9.250), duration of cancer (OR 
0.966, 95% CI 0.966-0.998), ongoing 
chemotherapy (OR 3.045, 95% CI 
1.149-8.067), pain perception (OR 
3.230, 95% CI 1.257-8.303), absence 
of sexual intercourse (OR 1.862) and 
three domains of quality of  life such 
as physical health, psychological health 
and social relationship (OR 0.942, 95% 
CI 0.908-0.978; OR 0.955, 95% CI 
0.916-0.995; OR 0.933, 95% CI 0.894-
0.973 respectively). 
 Logistic regression analysis of the 
deemed significant variables however, 
did not show any significant association. 
This could be due to small sample size. 
DISCUSSION
Even though there were no significant 
association based on binary logistic 
regression, there is no doubt that many 
confounders were operating which were 
masking associations.  The prevalence 
of sexual dysfunction among married 
gynaecological cancer patients was 
65%. This result was consistent with 
other studies done worldwide which 
stated the range from 40 to 100% 
(Anderson 1990; Casey 1996; Taylor 
2000). Consistent with a study by 
Schover et al. (1998), the most common 
sexual problem for gynaecological 
cancer patients was sexual desire 
dysfunction. Gynaecological cancer 
patients are often able to reach sexual 
orgasm. However, it may be delayed 
due to cancer treatment, depression or 
anxiety (Schover 1997). Sexual orgasm 
dysfunction had the least prevalence, 
sharing the same prevalence as sexual 
pain disorder. According to studies 
(Schover 1997; Ganz et al. 1998; 
Broeckel et al. 2002), many sexual 
problems, even under favorable 
circumstances, may not resolve within 
the first two years of disease-free 
survival or may remain constant or 
even continue to increase. This could 
possibly explain that married cancer 
patients in this study with absence 
of sexual intercourse for more than 
one month accounted for more than 
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Table 1: Sexual dysfunction in relation to psychosocial, medical variables and quality 
of life domains




Absence of Sexual Intercourse for >1 
month No
29 10 50.29 <0.001*
Yes 0 44
Ethnic Malay 20 31 3.15 0.369
Chinese 6 13
Indian 1 8




Education Level Low 5 21 4.11 0.043*
High 24 33










Husband Helps in Household No 8 17 0.14 0.712
Yes 21 37
Husband’s Presence at Home No 1 3 0.00 p>0.05
Yes 28 51
Presence of Children < 18 years old No 16 37 1.46 0.228
Yes 13 17
Perceived Social Support No 6 13 0.12 0.726
Yes 23 4





Staging of Cancer Early 13 17 1.46 0.228
Advanced 16 37
Metastasis No 22 37 0.50 0.482
Yes 7 17
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half (53%) and there was association 
between this and sexual dysfunction.
 The present study indicated that those 
with low education level experienced 
more sexual dysfunction. This might 
be due to the lack of understanding of 
their sexual difficulties and resources in 
getting treatment that could allay their 
sexual problems.
 In the present study, patients with 
shorter cancer duration had higher 
prevalence of sexual dysfunction. 
Initial phase of diagnosis can be more 
distressing to some patients because 
they may experience direct or indirect 
sexual side effects of treatment. They 
are worried that sexual intercourse will 
further injure their diseased sexual organ 
Recurrence No 23 42 0.03 0.872
Yes 6 12
Operation No 2 8 0.49 0.482
Yes 27 46
Ongoing Chemotherapy No 21 25 5.21 0.022*
Yes 8 29
Completed Chemotherapy No 20 33 0.50 0.478
Yes 9 21
Radiotherapy No 21 39 0.00 0.985
Yes 8 15
Pain Perception No 19 20 6.14 0.013*
Yes 10 34
Perceived Causal Attribution Unknown 17 26 0.89 0.642
Internal 3 6
External 9 22
Medical Illness No 11 27 1.11 0.293
Yes 18 27
Major Depressive Disorder No 25 4 1.22 0.268
Yes 41 13
Past Psychiatric Illness No 29 45 3.83 0.05
Yes 0 9
Family History of Psychiatric Illness No 25 49 0.07 0.792
Yes 4 5
Table 2: Sexual dysfunction in relation to age and duration of cancer
Sexual Dysfunction Mean/Mean Rank p level
Age Absence 49.9 years
Student’s t test 0.731
Presence 49.7 years
Duration of Cancer Absence 49.50months
Mann-Whitney U test 0.038*
Presence 37.97months
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or they may have cancer recurrence as 
long as the survival period is not over. 
The experience of the pain makes them 
handicap while performing sexual 
acts and cause emotional and spiritual 
disturbances which result in sexual 
dysfunctions.  
 Ongoing chemotherapy was 
associated with sexual dysfunction. 
This could be due to the direct 
and indirect side effects of the 
chemotherapy that cause the sexual 
dysfunction (Amsterdem & Krychman 
2008; Schover 1997; Anderson 1999; 
Auchincloss et al. 1998).
 In the present study, there was 
no association between sexual 
dysfunction and major depressive 
disorder. This could be explained that 
when life threatening cancer became 
the major concern for the cancer 
patients, they were less disturbed by the 
sexual dysfunction. They might be so 
depressed that sexual problem was not 
as problematic as the depression itself. 
The distress due to sexual problem 
might become concern only after 
survival of cancer or stability of health 
was restored or guaranteed. This could 
be after 3 to 5 years of its diagnosis. 
Other possible explanation was that the 
cancer patients in their reproductive age 
in this study were minority (18%) where 
sexual intercourse might not serve the 
important purpose of reproduction. It 
was also possible that patients who had 
sexual problem might attribute it to their 
menopausal syndrome which they had 
to experience one day, they might not 
be overly concerned about its effect on 
sexual problems. Another possibility 
was that these women might also 
view sexual problem as a commonly 
shared problem among gynaecological 
cancer patients and thus became less 
distressed. 
 Cancer patients who had sexual 
dysfunction obtained lower scores 
in the physical health, psychological 
health and social relationship domains 
of quality of life. Sexual dysfunction 
and poor quality of life are bothersome 
to many cancer patients. This may 
interfere with a return to normal 
post-treatment life. Assessment, 
referral, intervention, and follow-up 
are mandatory for improving sexual 
dysfunction to maximize quality of life 
(Ganz et al. 1998). 
CONCLUSION
Sexual dysfunction is highly prevalent 
in gynaecological cancer patients who 
were married and various risk factors 
were also involved. 
REFERENCES
American Psychiatric Association. 1994. Diagnostic 
and statistical manual of mental disorders 
DSM-IV, 4th edition. Washington: American 
Psychiatric Association. http://justines2010blog.
files.wordpress.com/2011/03/dsm-iv.pdf [9 May 
2014].
Amsterdam, A., Krychman, M. 2008. Sexual Function 
in Gynecologic Cancer Survivors. Expert Rev 
Obstet Gynecol 3(3): 331-7.
Anderson, B.L. 1990. How cancer affects sexual 
functioning. Oncology 4: 81-94.
Anderson, B.L. 1999. Surviving cancer: the 
importance of sexual self-concept. Med Pediatr 
Oncol 33(1): 5-23.
Auchincloss, S.S., McCartney, C.F. 1998. Gynecologic 
cancer. In: Psych-oncology. Edited by Holland 
JC. Breitbart W, Jacobsen PB, Lederberg MS, 
Loscalzo M, Massie MJ, McCorkle R. New York: 
Oxford University Press; 359-70.
Brock, G., Laumann, E., Glasser, D.B., Nicolosi, A., 
Gingell, C., King, R. 2003. Prevalence of sexual 
dysfunction among mature men and women 
in USA, Canada, Australia and New Zealand. 
Journal of Urology 163: 888-93.
61
Sexual Dysfunction in Gynaecological Cancer Patients Med & Health 2014; 9(1): 53-61
Broeckel, J.A., Thors, C.L., Jacobsen, P.B., Small, M., 
Cox, C.E. 2002. Sexual functioning in long-term 
breast cancer survivors treated with adjuvant 
chemotherapy. Breast Cancer Res Treat 75(3): 
241-8.
Casey, C. 1996. Psychosexual morbidity following 
gynaecological malignancy. Ir Med J 
 89(6): 200-2.
Ganz, P.A., Rowland, J.H., Desmond, K., Meyerowitz, 
B.E., Wyatt, G.E. 1998. Life after breast cancer: 
understanding women’s health-related quality 
of life and sexual functioning. J Clin Oncol 
16(2): 501-4.
Hasanah, C.I., Naing, L., Rahman, A.R. 2003. World 
Health Organization Quality of life Assessment: 
brief version in Bahasa Malaysia. Med J Malaysia 
58(1): 79-88.
Laumann, E.O., Paik, A., Rosen, R.C. 1999. Sexual 
dysfunction in United States: prevalence and 
predictors. JAMA 281(6): 537-44.
Lim, G.C.C., Halimah, Y. 2004. Cancer Incidence in 
Malaysia 2003. Second Report of the National 
Cancer Registry. Kuala Lumpur: National Cancer 
Registry. http://www.crc.gov.my/wp-content/
uploads/documents/report/2nd%20National%20
Cancer%20Registry.pdf [9 May 2014].
Marwick, C. 1999. Survey says patients expect little 
physician help on sex. JAMA 281(23): 2173–4.
Nicolosi, A., Glasser, D.B., Kim, S.C., Marumo, K., 
Laumann, E.O. 2005. Sexual behaviour and 
dysfunction and help-seeking patterns in adults 
aged 40-80 years in the urban population of 
Asian countries. BJU Int 95(4): 609-14.
Schover, L.R. 1997. Sexuality and Fertility after 
Cancer. New York: John Wiley and Sons; 5-10.
Schover, L.R., Jensen, S.B. 1998. Sexuality and 
chronic illness: A comprehensive approach. 
New York: Guilford Press; 10-20.
Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, 
P., Janavs, J., Weiller, E., Hergueta, T., Baker, 
R., Dunbar, G.C. 1998. The Mini-International 
Neuropsychiatric Interview (M.I.N.I.): the 
development and validation of a structured 
diagnostic psychiatric interview for DSM-IV and 
ICD-10. J Clin Psychiatry 59(suppl 20): 20-33.
Sidi,  H., Abdullah, N., Puteh, S.E., Midin, M. 2007. 
The Female Sexual Function (FSFI): validation of 
the Malay version. J Sex Med  4(6): 1642-54.
Taylor, E.J. 2000. Transformation of tragedy among 
women surviving breast cancer. Oncol Nurs 
Forum 27(5): 781-8.
